Bitcoin and altcoins experienced sudden and sharp declines this week. The price of BTC fell below $100,000, while altcoins also experienced double-digit declines.
However, while Bitcoin and altcoins experienced a slight recovery last night, cryptocurrency analysis company Santiment announced the most popular altcoins in the cryptocurrency world in its latest post.
Accordingly, Santiment said that investors showed great interest in altcoins named Bitcoin (BTC), Ethereum (ETH), Solana (SOL), Ripple USD (RLUSD), Chainlink (LINK) and NewYorkCoin (NYC).
Bitcoin leads the trending cryptocurrencies in the last 24 hours, followed surprisingly by NewYorkCoin, RLUSD, ETH, SOL, and LINK.
The cryptocurrencies that have attracted the most attention in the crypto industry and the reasons are listed as follows:
Bitcoin: BTC’s price cycles are trending due to discussions surrounding price predictions, whale selling, and buying. This reflects strong interest in Bitcoin as a long-term investment, its use in cryptocurrency trading, and increased market volatility.
NewYorkCoin: It is on the agenda due to the 2025 New York Mayoral elections won by Zohran Mamdani.
Ripple USD: Ripple is trending due to its partnerships with Mastercard, WebBank, and Gemini. RLUSD facilitates credit card transactions and uses XRP for transaction fees through its partnership with Mastercard, WebBank, and Gemini. This trend highlights RLUSD’s role in next-generation fiat payments and its growing importance within the Ripple ecosystem.
Ethereum: ETH’s recent price drop, ETF outflows of around $219 million, is trending due to comparisons with Bitcoin and other altcoins.
Solana: It is trending due to its frequent inclusion in numerous social media posts related to various new tokens and projects on the SOL blockchain.
Chainlink: It’s been trending lately for its partnerships. Discussions center on its partnerships with major financial institutions like S&P Dow Jones and its involvement in initiatives like the S&P Digital Markets 50 Index.
*This is not investment advice.